Early anti-coagulation therapy in new-onset atrial fibrillation after coronary artery bypass grafting: a randomized trial pilot study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early anti-coagulation therapy in new-onset atrial fibrillation after coronary artery bypass grafting: a randomized trial pilot study

Published:2024-08-02 Issue:1 Volume:24 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Ghavami Mojgan,Hosseini Kaveh,Abdshah Alireza,Abadi Shahryar Rajai Firouz,Akbarzadeh Diba,Mohammadi Ida,Kalhor Parvin,Sadeghian Saeed

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12872-024-04064-x.pdf

Reference35 articles.

1. Filardo G, Damiano RJ Jr., Ailawadi G, Thourani VH, Pollock BD, Sass DM, et al. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart. 2018;104(12):985–92.

2. Taha A, Nielsen SJ, Bergfeldt L, Ahlsson A, Friberg L, Bjorck S, et al. New-Onset Atrial Fibrillation after coronary artery bypass grafting and long-term outcome: a Population-based Nationwide Study from the SWEDEHEART Registry. J Am Heart Assoc. 2021;10(1):e017966.

3. Schwann TA, Al-Shaar L, Engoren MC, Bonnell MR, Goodwin M, Schwann AN, Habib RH. Effect of new-onset atrial fibrillation on cause-specific late mortality after coronary artery bypass grafting surgery. Eur J Cardiothorac Surg. 2018;54(2):294–301.

4. Wolf P, Abbott RJS, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. 1991;22(8):983–8.

5. Liu PH, Liu ZH, Niu MH, Chen P, Shi YB, He F, Guo R. A comparative study of the clinical benefits of Rivaroxaban and Warfarin in patients with non-valvular atrial fibrillation with high bleeding risk. Front Cardiovasc Med. 2022;9:803233.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Ongoing Registered Research Studies on Post-Operative Atrial Fibrillation after Cardiac Surgery;Journal of Clinical Medicine;2024-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3